These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3335582)

  • 1. Synergistic antiproliferative effects of glucocorticoids and interferon-alpha on some lymphoid cell lines.
    Elliott KR; Princler GL; Urba WJ; Faltynek CR
    J Cell Physiol; 1988 Jan; 134(1):85-92. PubMed ID: 3335582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
    Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antitumor effects of human natural and recombinant interferons (alpha and beta) on human cancer cell lines.
    Motoo Y; Hill NO; Osther K
    Jpn J Exp Med; 1986 Feb; 56(1):13-8. PubMed ID: 3014184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
    Pfeffer LM; Donner DB
    Cancer Res; 1990 May; 50(9):2654-7. PubMed ID: 2139358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the antiproliferative activity of human interferon by polyamine depletion.
    Kovach JS; Svingen PA
    Cancer Treat Rep; 1985 Jan; 69(1):97-103. PubMed ID: 3917854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon.
    Hubbell HR; Craft JA; Leibowitz PJ; Gillespie DH
    J Biol Response Mod; 1987 Apr; 6(2):141-53. PubMed ID: 3108460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent cytotoxic action of human recombinant alpha-interferon (Ro22-8181) in vitro and the sensitivity of various cultured leukemia and lymphoma cell lines to it.
    Shibata T; Shimada Y; Shimoyama M
    Jpn J Clin Oncol; 1985 Mar; 15(1):67-75. PubMed ID: 3981816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effects of natural human tumor necrosis factor-alpha and natural human interferon-alpha or -gamma on human cancer cell lines.
    Shiiki S; Fuchimoto S; Orita K
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):87-97. PubMed ID: 2501839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines.
    Pan LY; Guyre PM
    Cancer Res; 1988 Feb; 48(3):567-71. PubMed ID: 3121176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic regulatory effects of TNF alpha, IL-1 alpha and IFN alpha on the growth and differentiation of Daudi lymphoma cells.
    Santavenere E; Di Pietro R; Centurione MA; Di Domenicantonio L; Trubiani O; Rana RA
    Cell Biol Int; 1996 May; 20(5):335-8. PubMed ID: 8688848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
    Borden EC; Hogan TF; Voelkel JG
    Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between growth inhibition and presence of 5'-methylthioadenosine in cells treated with interferon.
    de Ferra F; Baglioni C
    Cancer Res; 1984 Jun; 44(6):2297-301. PubMed ID: 6426777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
    Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J
    Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant interferons on the clonogenic growth of leukemic cells and normal hemopoietic progenitors.
    Hosoi T; Ozawa K; Urabe A; Takaku F
    Int J Cell Cloning; 1985 Sep; 3(5):304-12. PubMed ID: 3930631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiproliferative activities of interferon-alpha].
    Ishii K; Yoshida H; Yanagihara Y; Kiyonaga J; Shirahama T
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1983-9. PubMed ID: 4051515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
    Faltynek CR
    Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
    Yano H; Yanai Y; Momosaki S; Ogasawara S; Akiba J; Kojiro S; Moriya F; Fukahori S; Kurimoto M; Kojiro M
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1720-5. PubMed ID: 16984596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.